NeOnc Technologies Holdings is trading at $3.10, up 5.08%, with no identified catalyst for the gain. - No reliable report identifies an October 23 catalyst or directly links the move to company news. - The Abu Dhabi research MoU, announced October 21, is nonbinding; available coverage does not establish it as the reason for the session’s move. - The broader biotech sector is down, so sector weakness does not explain the stock’s rise.